Both medicines affect GLP-1 pathways and share a dominant side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, especially during dose escalation
Important safety note: Because retatrutide is unlicensed in the UK, there is no MHRA-approved Summary of Product Characteristics or monitoring recommendations for routine clinical use, and there is no regulated supply chain
You may be a strong candidate for a medically supervised weight loss program if you: Have struggled to reach or maintain a healthy weight through diet and exercise alone Have a BMI in the range where these medications are appropriate Have weight-related health concerns such as high blood pressure or elevated blood sugar Are ready to pair medication with sustainable nutrition and lifestyle changes Want ongoing medical guidance rather than a one-time prescription This is exactly what a structured medical weight-loss program is designed to sort out
How fast you see results is a personal experience that depends on your lifestyle, genetics, and diet
Allergen Information: Contains soy
But for doctors and policymakers, the coming wave of generics raises harder questions: Will cheaper semaglutide meaningfully curb Indias obesity epidemic